Viking Therapeutics Inc (VKTX): Qarzning balans kapitallashuviga nisbati
Baxolash vositasi bo'lib xizmat qiluvchi Viking Therapeutics (VKTX) narxlar grafigi, innovatsiya xarajatlarini qoplaydigan yangi investitsiyalar oqimi tufayli barqarorlikni namoyish etmoqda, bunda ko'rsatkich hozirda 0.01 darajasida. Biznes testlarni o'tkazish uchun tashqi pudratchilarga tayanadi, bu esa kapital xarajatlarini kamaytiradi. Biroq, klinik sinovlar natijalariga yuqori bog'liqlik va soha gigantlarining bosimi aksiyalar narxining keskin pasayishi xavfini yuzaga keltirmoqda.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_VKTX_-_Viking-Therapeutics_-_Debt-to-Net-Assets-Ratio "VKTX: Viking Therapeutics, Inc. Qarzning balans kapitallashuviga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Viking Therapeutics kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Viking Therapeutics|VKTX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Viking Pharma|VKTX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Viking Therapeutics Corp|VKTX - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi Viking Therapeutics|Tezkor likvidlik koeffitsiyenti vikingtherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
Kompaniyaning fundamental tahlili:Viking Therapeutics VKTX
Professional investor aktivlar barqarorligini umumiy majburiyatlarning kapitalga nisbati orqali baholaydi, bunda ushbu ko'rsatkichning pasayishi to'lov qobiliyatining oshganini tasdiqlaydi. Kapitalizatsiyaga nisbatan qarzdorlik koeffitsiyentini tahlil qilish orqali Viking Therapeutics (VKTX) ning diversifikatsiyalashgan molekulyar portfeli moliyaviy risklarni qanday minimallashtirishi va klinik sinovlar davrida biznes uchun fundamental xavfsiz boshpana yaratishi ko'rinadi.
Raqobatdosh kompaniyalar tahlili
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|Qarzning balans qiymatiga nisbati SUPN|Qarzning balans kapitallashuviga nisbati CPRX|Balans kapitallashuviga qarzlar DNLI|Sof aktivlarga qarzlar Harmony Biosciences Inc|Qarzning balans kapitallashuviga nisbati Biohaven Pharmaceutical BHVN|Balans kapitallashuviga qarzlar Amylyx Corp AMLX|Trevi Therapeutics - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar praxismedicines.com PRAX|Anavex Life Sciences Corp. (AVXL) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati CBLL|PRTA (Prothena Corporation) - Balans kapitallashuviga qarzlar|ALEC - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati ANNX (Annexon, Inc.)|OMER (omeros.com) - Qarzning sof aktivlarga nisbati|Neurogene - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati ACIU (AC Immune S.A.)|Voyager Pharma - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati NMRA (Neumora Corp)|SCLX: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar tevogen.com (TVGN)|Qarzning balans kapitallashuviga nisbati Alpha Cognition Inc|CGTX: Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar IKT|Balans kapitallashuviga qarzlar Cassava Pharma (SAVA)|Qarzning balans kapitallashuviga nisbati Assertio ASRT|COYA (Coya Therapeutics Inc) - Qarzlarning balans kapitallashuviga nisbati|VistaGen Therapeutics Inc - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Ovid Therapeutics Inc.|ABOS (Acumen Pharma) - Qarzning balans qiymatiga nisbati|CervoMed Corporation (CRVO) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati ATHE|CLNN (Clene Nanomedicine) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar PEPG|Sof aktivlarga qarzlar Jupiter Neurosciences, Inc.|Balans kapitallashuviga qarzlar RLMD (Relmada)|ANVS - Qarzning balans qiymatiga nisbati|GRCE - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar fireflyneuro.com AIFF|KLTO (anewmeds.com) - Qarzning balans qiymatiga nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Reviva Pharmaceuticals Holdings|Balans kapitallashuviga qarzlar MetaVia, Inc.|Qarzning balans qiymatiga nisbati NRXS (NeurAxis, Inc.)|Qarzning balans kapitaliga nisbati HSDT|Passage Bio - Qarzning balans qiymatiga nisbati|NEUP: Qarzning balans qiymatiga nisbati|NERV - Qarzning balans kapitallashuviga nisbati|ATHA (Athira Pharma Corp) - Qarzning balans qiymatiga nisbati|ADXN: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Alzamend Neuro (ALZN)|Qarzning balans qiymatiga nisbati CYCN|Balans kapitallashuviga qarzlar Protagenic|Qarzning balans kapitallashuviga nisbati Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics ATXI|brainstorm-cell.com (BCLI) - Balans qiymatiga qarzlar|CARA: Qarzning balans qiymatiga nisbati|CHRO: Qarzning balans kapitallashuviga nisbati|ELYM: Balans kapitallashuviga qarzlar|ITCI - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|Balans kapitallashuviga qarzlar marinuspharma.com|Balans kapitallashuviga qarzlar NKGN|Sof aktivlarga qarzlar NeuroBo Pharmaceuticals Inc|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc SAGE|SNPX: Qarzning balans qiymatiga nisbati|Trevena, Inc. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Vigil Neuroscience (VIGL)|WENA (Anew Medical) - Qarzning balans qiymatiga nisbati|Cerevel Therapeutics Inc - Qarzning sof aktivlarga nisbati